Lung transplantation is an option for appropriately selected patients with end-stage emphysema caused by α1-antitrypsin deficiency. The functional results have been excellent after single or bilateral lung transplantation, and the medium-term survival results have been good. However, the role of α1-antitrypsin replacement therapy after lung transplantation remains uncertain, and further investigation is needed.
|Issue number||6 SUPPL.|
|State||Published - 1996|
- antitrypsin deficiency
- chronic obstructive pulmonary disease
- lung transplantation